PharmaLex Denmark A/S — Credit Rating and Financial Key Figures

PharmaLex Denmark A/S (CVR number: 18652439) is a company from RUDERSDAL. The company recorded a gross profit of 26 mDKK in 2024. The operating profit was 2251 kDKK, while net earnings were 1745.7 kDKK. The profitability of the company measured by Return on Assets (ROA) was 17.7 %, which can be considered excellent and Return on Equity (ROE) was 31.2 %, which can be considered excellent. The equity ratio, a key indicator for solidity, stood at 47.6 %, a level that can be considered to be modest. This means a balanced mix of debt and equity financing its assets—a typical operational level for many companies. PharmaLex Denmark A/S's liquidity measured by quick ratio was 1.8 which is at a very high level. Thus, the company demonstrates exceptional financial stability, possessing a significant surplus of liquid assets over its short-term liabilities.